Browse All

Current Filters

CLEAR FILTER x

TITLE

Investigating the Side Effects of Treatments Among Different Age and Gender Groups of Multiple Sclerosis Patients

Author:Çakan, Melike   Çakan, Elif   Gümüs, Yasemin   Acar Özen, Pinar   Tuncer, Asli   Karabudak, Rana   

Session Name:P2: Multiple Sclerosis: Clinical Practice and Decision Making 2  

Topic:Multiple Sclerosis  

Program Number:P2.015  

Author Institution:Hacettepe University School of Medicine, Department of Neurology, Altindag, Turkey  Hacettepe University School of Medicine, Ankara, Turkey  Academic Neurologist, Ankara, Turkey  

A Case of Immune Checkpoint Inhibitor (ICI) Use in Multiple Sclerosis

Author:Patel, Hemali   Hutton, George   

Session Name:P2: Multiple Sclerosis: Clinical Practice and Decision Making 2  

Topic:Multiple Sclerosis  

Program Number:P2.016  

Author Institution:Baylor College of Medicine, Houston, TX  

Dilemmas and Delays: Management of Multiple Sclerosis in the Outpatient Setting

Author:Muddasani, Varsha   Khurana, Shikhar   Naik, Sahil   Prabhu, Aparna   

Session Name:P2: Multiple Sclerosis: Clinical Practice and Decision Making 2  

Topic:Multiple Sclerosis  

Program Number:P2.017  

Author Institution:Einstein Medical Center, Philadelphia, PA  

Balloon Rhizotomy for the Treatment of Refractory Trigeminal Neuralgia Secondary to Multiple Sclerosis: A Case Series

Author:Bondoc, Christopher   Cheng, Hsinlin   Schweitzer, Jeffrey   Heffernan, Megan   

Session Name:P2: Multiple Sclerosis: Clinical Practice and Decision Making 2  

Topic:Multiple Sclerosis  

Program Number:P2.018  

Author Institution:True North Neurology, Port Jefferson Station, NY  Massachusettes General Hospital, Boston, MA  MGH, Boston, MA  

MS Relapse Redefined: Distinguishing True Relapses from Pseudoexacerbations in the ULTIMATE I and II Trials Comparing Ublituximab vs Teriflunomide

Author:Krieger, Stephen   Bodhinathan, Karthik   Xu, Yihuan   Miskin, Hari   Lee, Lily   Alvarez, Enrique   

Session Name:P3: Multiple Sclerosis: Therapeutics and Symptom Management  

Topic:Multiple Sclerosis  

Program Number:P3.001  

Author Institution:Mount Sinai Dept of Neurology, New York, NY  TG Therapeutics, New York, NY  University of Colorado, Aurora, CO